Cargando…
Guifu Dihuang Pills Ameliorated Mucus Hypersecretion by Suppressing Muc5ac Expression and Inactivating the ERK-SP1 Pathway in Lipopolysaccharide/Cigarette Smoke-Induced Mice
Mucus hypersecretion is a hallmark of chronic obstructive pulmonary disease (COPD) and is associated with increasing sputum production and declining pulmonary function. Therefore, reducing mucus secretion can be a new therapeutic opportunity for preventing COPD. The Guifu Dihuang pill (GFDHP) is a c...
Autores principales: | Zhang, Huanhuan, Yu, Wenying, Ji, Liting, Zhong, Yusen, Lin, Yiyou, Ying, Huazhong, Yu, Chenhuan, Li, Changyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580658/ https://www.ncbi.nlm.nih.gov/pubmed/34777538 http://dx.doi.org/10.1155/2021/9539218 |
Ejemplares similares
-
ITGB4 deficiency induces mucus hypersecretion by upregulating MUC5AC in RSV-infected airway epithelial cells
por: Du, Xizi, et al.
Publicado: (2022) -
Airway Mucus and Asthma: The Role of MUC5AC and MUC5B
por: Bonser, Luke R., et al.
Publicado: (2017) -
Neutrophil extracellular traps promote lipopolysaccharide-induced airway inflammation and mucus hypersecretion in mice
por: Zou, Yong, et al.
Publicado: (2018) -
Bronchial Thermoplasty for Severe Asthma with Mucus Hypersecretion
por: Nagano, Naoko, et al.
Publicado: (2019) -
Association of the CFTR gene with asthma and airway mucus hypersecretion
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2021)